Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke | Zendy

Akira Ogawa | Zendy; Etsuro Mori | Zendy; Kazuo Minematsu | Zendy; Waro Taki | Zendy; Akira Takahashi | Zendy; Shigeru Nemoto | Zendy; Susumu Miyamoto | Zendy; Makoto Sasaki | Zendy; Takashi Inoue | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke

Author(s) -

Akira Ogawa,

Etsuro Mori,

Kazuo Minematsu,

Waro Taki,

Akira Takahashi,

Shigeru Nemoto,

Susumu Miyamoto,

Makoto Sasaki,

Takashi Inoue

Publication year - 2007

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.107.488551

Subject(s) - medicine , modified rankin scale , urokinase , stroke (engine) , middle cerebral artery , randomized controlled trial , randomization , clinical endpoint , clinical trial , surgery , anesthesia , tissue plasminogen activator , ischemia , ischemic stroke , mechanical engineering , engineering

The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan was organized to determine the safety and clinical efficacy of intraarterial infusion of urokinase (UK) in patients with stroke within 6 hours of onset.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research